GalNAc Cluster Amide C7 Linker DMT Succinate LCAA CPG 1000 A
GalNAc Cluster Amide C7 Linker DMT Succinate LCAA CPG 1000 A
製品概要
クイックビュー
- 製品ファミリー
- Oligonucleotide Conjugation & Delivery Ligands
- 化学名
- GalNAc Cluster Amide C7 Linker DMT Succinate LCAA CPG 1000 A
CH52004 is listed as GalNAc Cluster Amide C7 Linker DMT Succinate LCAA CPG 1000 A.
The catalog record does not include CAS, formula, MW, support loading, PubChem CID, or pore-size specification for the exact product.
Controlled-pore-glass supports are described in solid-phase oligonucleotide synthesis literature, and GalNAc-CPG appears in broader GalNAc conjugate discussion. Those references do not verify CH52004 support structure, loading, or performance.
同定情報と仕様
| Catalog No. | CH52004 |
| Product Name | GalNAc Cluster Amide C7 Linker DMT Succinate LCAA CPG 1000 A |
| CAS No. | Not assigned |
| Formula / MW | Not listed |
| Support Loading | Not listed |
| Public CID | No public CID cited |
用途情報
- CPG support published studies for solid-phase oligonucleotide synthesis
- GalNAc ligand chemistry research
補足材料情報
用途
This catalog entry is limited to support identity information. Loading, pore size, and support-specific specifications are not included.
特性
The catalog name indicates a GalNAc cluster on a DMT succinate LCAA CPG support. Structure, loading, pore size, and support specifications are not included in the catalog record.
関連技術資料
公開情報源
- Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency in mice
Nucleic Acids Research, 2014
Product-family technical context
- Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits RNAi-mediated gene silencing
Journal of the American Chemical Society, 2014
Product-family technical context
- siRNA Conjugates Carrying Sequentially Assembled Trivalent N-Acetylgalactosamine Linked Through Nucleosides Elicit Robust Gene Silencing In Vivo in Hepatocytes
ACS Chemical Biology, 2015
Product-family technical context
- Comparative Characterization of Hepatic Distribution and mRNA Reduction of Antisense Oligonucleotides Conjugated with Triantennary N-Acetyl Galactosamine and Lipophilic Ligands
Journal of Pharmacology and Experimental Therapeutics, 2016
Product-family technical context
よくある質問
What is CH52004 listed as?
CH52004 is listed as GalNAc Cluster Amide C7 Linker DMT Succinate LCAA CPG 1000 A.
Are loading and pore size verified?
No. available data treat support loading and pore-size specification as Not listed.
What context can be shown safely?
Only general CPG support and GalNAc ligand research are shown because support specifications are not included.
類似製品
材料選択の支援が必要ですか？
CHEMOSは製品適合性、目標構造、ルート上の課題、分析要件、プロジェクト別供給ニーズを確認します。